BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yim C, Mansell K, Hussein N, Arnason T. Current cancer therapies and their influence on glucose control. World J Diabetes 2021; 12(7): 1010-1025 [PMID: 34326951 DOI: 10.4239/wjd.v12.i7.1010]
URL: https://www.wjgnet.com/2307-8960/full/v12/i7/1010.htm
Number Citing Articles
1
Abutaleb Asiri, Ali Al Qarni, Ahmed Bakillah. The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic InsightsDiagnostics 2024; 14(19): 2132 doi: 10.3390/diagnostics14192132
2
Elizabeth R. Stirling, Steven M. Bronson, Jessica D. Mackert, Katherine L. Cook, Pierre L. Triozzi, David R. Soto-Pantoja. Metabolic Implications of Immune Checkpoint Proteins in CancerCells 2022; 11(1): 179 doi: 10.3390/cells11010179
3
Terra Arnason, Kerry Mansell. The Juncture of Diabetes, Cancer, and Observational Population-based Studies: Novel Insights From Canadian Provincial Health RecordsCanadian Journal of Diabetes 2024; 48(3): 145 doi: 10.1016/j.jcjd.2024.02.002
4
Xin-Yu Liang, Li-yuan Mu, Lei Hu, Rui-ling She, Chen-yu Ma, Jun-han Feng, Zhi-yu Jiang, Zhao-xing Li, Xiu-quan Qu, Bai-qing Peng, Kai-nan Wu, Ling-quan Kong. Optimal Glycated Hemoglobin Cutoff for Diagnosis of Diabetes and Prediabetes in Chinese Breast Cancer WomenInternational Journal of General Medicine 2024; : 1807 doi: 10.2147/IJGM.S457158
5
Joanna Stanisławiak-Rudowicz, Edyta Szałek, Barbara Więckowska, Edmund Grześkowiak, Radosław Mądry. Olaparib-induced hyperglycemia in ovarian cancer patients – a case series analysis of a three-month therapy with a consideration of BMIPharmacological Reports 2025; 77(2): 500 doi: 10.1007/s43440-025-00702-z
6
Bola Habeb, Otto Valdes, Sandy Khair, Gurmanpreet Sidhu, Matthew Fowler. Capivasertib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient With Metastatic Prostate Cancer With Bone Involvement: A Case Report of a Rare but Serious Metabolic ComplicationCureus 2025;  doi: 10.7759/cureus.81513
7
Harshita Thakur, Asmita Das. Comparative Analysis of in Silico Tools for Drug Side Effect Prediction2025 International Conference on Intelligent Control, Computing and Communications (IC3) 2025; : 295 doi: 10.1109/IC363308.2025.10956741
8
Christian Jenssen, Cristine Pietsch. Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische RelevanzDie Diabetologie 2022; 18(4): 379 doi: 10.1007/s11428-022-00897-2
9
Dominik J. Ose, Emmanuel Adediran, Bayarmaa Mark, Krista Ocier, William A. Dunson JR, Cindy Turner, Belinda Taylor, Kim Svoboda, Andrew R. Post, Jennifer Leiser, Howard Colman, Cornelia M. Ulrich, Mia Hashibe. The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort studyCancer Medicine 2024; 13(20) doi: 10.1002/cam4.70246
10
Susan Storey, Xiao Luo, Susan Ofner, Susan M. Perkins, Diane Von Ah. The role of glycemic control and symptoms and symptom clusters in breast cancer survivors with type 2 diabetesSupportive Care in Cancer 2025; 33(5) doi: 10.1007/s00520-025-09434-5
11
Maria V. Deligiorgi, Dimitrios T. Trafalis. A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint InhibitorsInternational Journal of Molecular Sciences 2023; 24(8): 7630 doi: 10.3390/ijms24087630
12
Angela Zanfardino, Patrizia Bruzzi, Michela Trada, Novella Rapini, Emanuela Laudani, Gianluca Tornese, Federica Ortolani, Gianluca Piccolo, Lorena Matonti, Maria Alessandra Saltarelli, Tiziana Timpanaro, Giuseppe D’Annunzio, Barbara Predieri, Francesca Rossi, Rossella Mura, Veronica Barat, Arcangelo Prete, Riccardo Schiaffini, Stefano Zucchini. The real-life management of glucose homeostasis abnormalities in pediatric onco-hematological diseases: data from a national surveyPediatric Hematology and Oncology 2024; 41(3): 198 doi: 10.1080/08880018.2023.2295454
13
Qiaoling Yang, Chuping Chen, Jianmin Ran. Capecitabine-induced severe diabetes and hypokalemia: a case reportJournal of Medical Case Reports 2022; 16(1) doi: 10.1186/s13256-022-03392-w
14
Isabel Sontag, Henning Adamek. Zielgerichtete onkologische Therapie mit metabolischen NebenwirkungenInfo Diabetologie 2024; 18(5): 6 doi: 10.1007/s15034-024-5013-z
15
Tomasz Klupa, Leszek Czupryniak, Grzegorz Dzida, Piotr Fichna, Przemyslawa Jarosz-Chobot, Janusz Gumprecht, Malgorzata Mysliwiec, Agnieszka Szadkowska, Dorota Bomba-Opon, Krzysztof Czajkowski, Maciej T. Malecki, Dorota A. Zozulinska-Ziolkiewicz. Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 DiseaseDiabetes Therapy 2023; 14(8): 1241 doi: 10.1007/s13300-023-01431-3
16
Mohamed Shouman, Michelle Brabant, Noor Rehman, Shahid Ahmed, Rabia K. Shahid. Perioperative Management of Patients with Diabetes and Cancer: Challenges and OpportunitiesCancers 2024; 16(16): 2821 doi: 10.3390/cancers16162821
17
Rashed Harun, Rucha Sane, Kenta Yoshida, Dhruvitkumar S. Sutaria, Jin Y. Jin, James Lu. Risk Factors of Hyperglycemia After Treatment With the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning–Based InvestigationJCO Clinical Cancer Informatics 2023; (7) doi: 10.1200/CCI.22.00168
18
Alfredo Caturano, Enes Erul, Roberto Nilo, Davide Nilo, Vincenzo Russo, Luca Rinaldi, Carlo Acierno, Maria Gemelli, Riccardo Ricotta, Ferdinando Carlo Sasso, Antonio Giordano, Caterina Conte, Yüksel Ürün. Insulin resistance and cancer: molecular links and clinical perspectivesMolecular and Cellular Biochemistry 2025;  doi: 10.1007/s11010-025-05245-8
19
Hongyu Wang, Xiao She, Qiongdong Xu, Xingyu Zhou, Qinchao Tang, Huakun Wei, Tianjing Huang, Feixin Liang. Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucoseOral Diseases 2024; 30(7): 4195 doi: 10.1111/odi.14893
20
Róbert János Bánhegyi, Blanka Veréb, Andrea Gazdag, Beatrix Rácz, Róbert Wagner, Norbert Fülöp, Béla Pikó. Onkodiabetológia III.Orvosi Hetilap 2022; 163(41): 1614 doi: 10.1556/650.2022.32635